Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-06-12
1988-11-22
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544319, A61K 31505, C07D23902
Patent
active
047866403
ABSTRACT:
Disclosed herein are 2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acids and pharmaceutically acceptable salts thereof and methods of their preparation. The compounds are new aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.
REFERENCES:
patent: 4234587 (1980-11-01), Maurer et al.
patent: 4505910 (1985-03-01), Bagli
patent: 4568693 (1986-02-01), Sestanj
patent: 4617393 (1986-10-01), Bagli
Noller, Textbook of Organic Chemistry, 3rd edition, W. B. Saunders Co., Philadelphia, 1966, pp. 139, 173.
Wolff, Burger's Medicinal Chemistry, 4th Ed., Part II, 1979, John Wiley & Sons, New York, pp. 1049-1057.
Alessi Thomas R.
Bagli Jehan F.
Ellingboe John W.
American Home Products Corporation
Patton Walter
Rotman Alan L.
Whittenbaugh Robert C.
LandOfFree
2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose red does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose red, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose red will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-435538